Medication
|
Benefit Category
|
Details
|
Link
|
| Abilify (aripiprazole) |
Regular Benefit
.................................... |
Covered by Plans A, C, D, E, F, G, V |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Abilify Maintena (aripiprazole LAI) |
Special Authorization |
For the treatment of patients who are: • not adherent to an oral antipsychotic, or • currently receiving a long-acting injectable antipsychotic and require an alternative long-acting injectable antipsychotic. |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Clozaril (clozapine) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Invega (paliperidone) |
Not a Benefit |
|
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Invega Sustenna (paliperidone palmitate) |
Special Authorization |
For the maintenance treatment of schizophrenia and related psychotic disorders (not dementia related) in patients who: • are not adherent to an oral antipsychotic, or • are currently receiving a long-acting injectable antipsychotic and require an alternative long-acting injectable antipsychotic. |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Invega Trinza (paliperidone palmitate) |
Special Authorization |
For the maintenance treatment of schizophrenia and related psychotic disorders (not dementia related) in patients who have been stabilized on therapy with injectable paliperidone for at least four months. |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Latuda (lurasidone) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Rexulti (brexpiprazole) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Risperdal (risperidone) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Risperdal Consta (risperidone LAI) |
Special Authorization |
For the treatment of patients who are: • not adherent to an oral antipsychotic, or • currently receiving a long-acting injectable antipsychotic and require an alternative long-acting injectable antipsychotic. |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Saphris (asenapine) |
Special Authorization |
For the acute treatment of bipolar I disorder as either: • Monotherapy, after inadequate response to a trial of lithium or divalproex sodium, and there is a history of inadequate response or intolerance to at least one less expensive antipsychotic agent; or • Co-therapy with lithium or divalproex sodium, and there is a history of inadequate response or intolerance to at least one less expensive antipsychotic agent. |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Seroquel (quetiapine) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V, W |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Zeldox (ziprasidone) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Zyprexa (olanzapine) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V, W |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Zyprexa IM (olanzapine IM) |
Not a Benefit |
|
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Clopixol (zuclopenthixol) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V
Zuclopenthixol acetate is not a benefit |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Fluanxol (flupentixol) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Modecate (fluphenazine) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Haldol (haloperidol) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V, W |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Largactil (chlorpromazine) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V, W |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Loxapac (loxapine) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V
The injectable formulation is not a benefit |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Majeptil (thioproperazine) |
Not a Benefit |
|
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Navane (thiothixene) |
Not a Benefit |
|
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Neuleptil (pericyazine) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Nozinan (methotrimeprazine) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V, W |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Orap (pimozide) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Stelazine (trifluoperazine) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Stemetil (prochlorperazine) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |
| Trilafon (perphenazine) |
Regular Benefit |
Covered by Plans A, C, D, E, F, G, V |
https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/NBDrugPlan/NewBrunswickDrugPlansFormulary.pdf |